 DOYLESTOWN, Pennsylvania, Nov. 16, 2020 GLOBE NEWSWIRE -- ProPhase Labs, Inc. NASDAQ: PRPH, a diversified medical science and technology company, today announced net sales of 3.8 million for the three months ended September 30, 2020, compared to net sales of 2.8 million for the three months ended September 30, 2019. The Company incurred a net loss from continued operations for the three months ended September 30, 2020 of 569,000, or 0.05 per share, compared to a net loss from continued operations of 428,000, or 0.04 per share, for the three months ended September 30, 2019. For the three months ended September 30, 2020, the Company also recognized income from discontinued operations of 161,000, or 0.01 per share. The Company incurred a net loss for the three months ended September 30, 2020 of 408,000, or 0.04 per share, compared to a net loss of 428,000, or 0.04 per share, for the three months ended September 30, 2019. 